F.D.A. Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats
The genetic testing service 23andMe is now authorized to report the mutations to its customers. [Source]
Publication Date:Origin: nytimes.com
Category: Tests (Medical)
Topics: customers, mutations, report, authorized, 23andMe, service, testing, genetic, Caveats, Mutations, Cancer, Breast, Testing, First, Approves
Source: https://www.nytimes.com/2018/03/06/well/fda-brca-home-testing.html?partner=rss&emc=rss